PYPD · Company research

PolyPid Ltd. Ordinary Shares (PYPD): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

17records availableHealthcare

Stock News & Events data

Database-backed records only

17 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
A new candidate for diabetic foot infections will be introduced at PolyPid's Oct. 28 investor event. - Stock TitanA new candidate for diabetic foot infections will be introduced at PolyPid's Oct. 28 investor event. Stock TitanView source ↗Stock TitanOct 15, 2026neutral00.6
Precision Trading with PYPD Inc (PYPD) Risk Zones - Stock Traders DailyPrecision Trading with PYPD Inc (PYPD) Risk Zones Stock Traders DailyView source ↗Stock Traders DailyOct 8, 2026neutral00.6
A drug designed to release antibiotics for 30 days clears an EU review step at PolyPid (PYPD). - Stock TitanA drug designed to release antibiotics for 30 days clears an EU review step at PolyPid (PYPD). Stock TitanView source ↗Stock TitanOct 1, 2026neutral00.6
A European licensing deal ends by mutual agreement between PolyPid (PYPD) and ADVANZ PHARMA. - Stock TitanA European licensing deal ends by mutual agreement between PolyPid (PYPD) and ADVANZ PHARMA. Stock TitanView source ↗Stock TitanOct 1, 2026neutral00.6
A treatment designed to prevent infections after abdominal surgery enters European review - Stock TitanA treatment designed to prevent infections after abdominal surgery enters European review Stock TitanView source ↗Stock TitanOct 1, 2026neutral00.6
Understanding Momentum Shifts in (PYPD) - Stock Traders DailyUnderstanding Momentum Shifts in (PYPD) Stock Traders DailyView source ↗Stock Traders DailySep 28, 2026neutral00.6
Understanding Momentum Shifts in (PYPD) - Stock Traders DailyUnderstanding Momentum Shifts in (PYPD) Stock Traders DailyView source ↗Stock Traders DailySep 28, 2026neutral00.6
PolyPid (PYPD): Will The November FDA Decision Propel The Stock? - RTTNewsPolyPid (PYPD): Will The November FDA Decision Propel The Stock? RTTNewsView source ↗RTTNewsAug 28, 2026neutral00.6
PolyPid Ltd (PYPD) Stock News Today - TradingKeyPolyPid Ltd (PYPD) Stock News Today TradingKeyView source ↗TradingKeyAug 7, 2026neutral00.6
PolyPid Wins FDA Priority Review for D-PLEX100 NDA, Accelerating Path to Market - The Globe and MailPolyPid Wins FDA Priority Review for D-PLEX100 NDA, Accelerating Path to Market The Globe and MailView source ↗The Globe and MailJul 30, 2026neutral00.6
PolyPid stock jumps as FDA accepts D-PLEX100 NDA with priority review - Investing.comPolyPid stock jumps as FDA accepts D-PLEX100 NDA with priority review Investing.comView source ↗Investing.comJul 29, 2026neutral00.6
PYPD Forecast — Price Target — Prediction for 2027 - TradingViewPYPD Forecast — Price Target — Prediction for 2027 TradingViewView source ↗TradingViewJun 27, 2026neutral00.6
When Can We Expect A Profit From PolyPid Ltd. (NASDAQ:PYPD)? - Simply Wall StreetWhen Can We Expect A Profit From PolyPid Ltd. (NASDAQ:PYPD)? Simply Wall StreetView source ↗Simply Wall StreetJun 8, 2026neutral00.6
PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀ - GlobeNewswirePolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀ GlobeNewswireView source ↗GlobeNewswireJun 1, 2026neutral00.6
$PYPD ($PYPD) Releases Q1 2026 Earnings - Quiver Quantitative$PYPD ($PYPD) Releases Q1 2026 Earnings Quiver QuantitativeView source ↗Quiver QuantitativeMay 13, 2026neutral00.6
When Will PolyPid Ltd. (NASDAQ:PYPD) Turn A Profit? - Yahoo FinanceWhen Will PolyPid Ltd. (NASDAQ:PYPD) Turn A Profit? Yahoo FinanceView source ↗Yahoo FinanceFeb 13, 2026neutral00.6
symbol__ Stock Quote Price and Forecast - CNNsymbol__ Stock Quote Price and Forecast CNNView source ↗CNNApr 6, 2024neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.